ANN ARBOR, Mich., Feb. 28, 2022 — The Allene Reuss Memorial Trust has awarded Eversight a grant to support virtual training opportunities for international surgeons and the placement of cornea tissue at low or no-cost in countries where the need is greatest.
The Allene Reuss Memorial Trust gives primarily to organizations that aid in the prevention and cure of vision problems. This aligns closely with Eversight’s mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. Through their gift, the Allene Reuss Memorial Trust will enable Eversight to provide training to 200 international surgeons and provide reduced-fee corneal tissue to 50 patients abroad who otherwise may not receive a second chance at sight.
Corneal blindness is the fourth-leading cause of blindness worldwide according to the World Health Organization. Globally, approximately 5 to 12.5 million people suffer from untreated corneal blindness and fifty-three percent of the world’s population has no access to corneal transplantation. The total global cost of blindness and visual impairment is more than $411 billion annually, according to a study by the Lancet Global Health Commission on Global Eye Health.
Eversight operates in international communities with high need for corneal transplantation. The global eye bank network partners with physicians, researchers, eye care institutions, government authorities, non-governmental organizations and other stakeholders to eliminate preventable corneal blindness by providing tissue in the short term, as well as helping foster greater in-country self-sufficiency through eye bank development efforts, clinical education and training opportunities.
“This new partnership with the Allene Reuss Memorial Trust is critical in reducing blindness globally,” said Collin Ross, Vice President of Global Development, Eversight. “We are thankful to the trustees and Board of Directors for their shared vision to create a world without blindness.”
Eversight is a nonprofit organization with a mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. The Eversight network is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. Operating in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea, Eversight works in collaboration with surgeons, researchers, academic medical centers and eye banks across the United States and abroad. For more information, visit eversightvision.org.